CongressBuys

SEC EDGAR · Company announcement

CACI: Leadership change

Filed 8-K for an event or period dated 2026-06-22. Leadership change.

Became public
Jun 22, 2026, 8:19 AM EDT
Event / period date
Jun 22, 2026
Collected
Nov 6, 2026, 10:39 AM EST

Why this is connected

This filing identifies CACI INTERNATIONAL INC /DE/ as the issuer of the security. The company's SEC identifier connects it to CACI.

Press Release dated June 22, 2026 ↗

Source evidence

Read the source excerpt or record
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 22, 2026, CACI International Inc (the “Company”) announced the appointment of Dr. David Young, 45, as the Company’s Chief Operating Officer reporting to the Chief Executive Officer. Dr. Young has 25 years of experience, most recently serving at Lockheed Martin as Vice President and General Manager National Security Space from December 2024 to June 2026, and as Vice President and Deputy General Manager National Security Space from September 2024 to December 2024. Prior to Lockheed, he served as Chief Operating Officer for CAES from January 2021 to September 2024. He also served as Vice President, Advanced Program Development for Lockheed Martin from April 2019 to January 2021 and held roles of increasing responsibility over 11 years at Northrop Grumman. Dr. Young will receive compensation, including participation in the Company’s annual bonus plan and long-term incentive program, customary for his position and scope of responsibilities within the Company. In addition, he will receive a one-time cash sign-on bonus in the amount of $500,000 and a grant of $2,000,000 in restricted stock units that will vest in three equal annual installments beginning on the first anniversary of his employment. There was no arrangement or understanding pursuant to which he was selected as an officer of the Company. There are no family relationships between him and any director or executive officer of the Company, or any person chosen by the Company to become a director or executive officer. There are no related party transactions of the kind described in Item 404(a) of Regulation S-K in which he was a par

Congressional trading in CACI

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.